Insights on Clinical Trials

  1. September's Top Content On Cell & Gene 9/29/2023

    Here is a glimpse of the impactful content, in various formats, Cell & Gene delivered this month.

  2. Proof-Of-Concept Study Enabled To Drive Novel Gene Therapy Program 9/29/2023

    Unearth how a natural history trial aimed at addressing the exceptionally rare neurological disease affecting pediatric patients with no existing treatment options was executed successfully.

  3. A Comprehensive Planning Approach For Cancer Antibody 9/29/2023

    Discover how a clinical-stage biotech company was able to accelerate pathways for development and regulatory review of their first Phase I protocol for an immuno-oncology antibody.

  4. Dr. Jim Wilson At LSPA’s Life Sciences Future Conference 9/28/2023

    LSPA's Life Science Future event included a plenary session featuring Jim Wilson Ph.D., M.D., Director, Gene Therapy Program Professor of Medicine and Pediatrics, Perelman School of Medicine at the University of Pennsylvania. Here's a recap of that session.

  5. The State Of CAR-T Research In China 9/27/2023

    While numerous opportunities are available for companies seeking to undertake CAR-T research in China, embarking on this path requires careful consideration.

  6. Advancing Policy To Improve Safety And Efficacy For Cell And Gene Therapies 9/22/2023

    Achieving greater specificity for cell and gene therapy regulatory guidance is crucial, but even more crucial is establishing guidance informed by patient experience.

  7. Where Biomarkers And Gene Therapy Trials Intersect 9/21/2023

    Gain insight into several pivotal aspects involving gene therapy clinical development for rare diseases, such as biomarker selections, accelerated approval methods, dose determination, and the potential for streamlining the duration of clinical trials.

  8. Factors That Could Influence Your Patient Participation Strategy 9/21/2023

    Review pertinent clarifications and insights concerning the optimization of the benefit-risk profile, considerations related to participation and consent, the role of volunteers, and the importance of customization.

  9. The Multi-Faceted World Of Clinical Trial Matching In Precision Oncology Studies 9/21/2023

    Delve into strategies aimed at heightening awareness of clinical trials among patients and healthcare providers (HCPs), enabling them to make informed decisions regarding potential involvement in pertinent studies.

  10. Establishing The Right-Sized Tech Ops Strategy In An Uncertain Market 9/20/2023

    A quantitative and qualitative tech ops strategy gives biotech companies a sound roadmap to guide them through the winding road of drug development and attract investors.